In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Cellectis S.A.. Trade Record

NASDAQ:CLLS Cellectis S.A. stock gains 9.06% Exit Sep 5, 2017 a Trade Record by priceseries

Trade Chart
Trade Chart CLLS Aug 22, 2017, priceSeries
About Cellectis S.A.

Developing cancer immunotherapies based on gene-edited CAR T-cells.

Trade Information
Trade Type
LONG
ReliabilityScore™
89.29
Entry Date
Aug 22, 2017
Entry Price
24.23
Sell Date
Sep 5, 2017
Sell Price
26.42
Net Gain
9.06%
Hold Time
9 Trading Days